SEC Declares S-4 Effective for Factorial Merger; Shareholder Vote Set for May 27
summarizeSummary
Cartesian Growth Corp III announced that the SEC declared its S-4 registration statement effective for the business combination with Factorial Inc., with the shareholder meeting scheduled for May 27, 2026, to approve the merger.
check_boxKey Events
-
S-4 Registration Effective
The joint S-4 registration statement for the business combination with Factorial Inc. was declared effective by the SEC on May 6, 2026.
-
Shareholder Meeting Scheduled
An extraordinary general meeting of shareholders is set for May 27, 2026, to vote on the proposed business combination.
-
Merger Timeline
The business combination is anticipated to close in June 2026, with the combined company expected to trade under ticker symbols "FAC" and "FACWW" on Nasdaq.
-
Financial Context
The SPAC holds approximately $287 million in cash in trust, and the merger includes a $100 million PIPE investment, projecting a pro forma equity value of $1.5 billion (assuming no redemptions).
auto_awesomeAnalysis
This filing marks a critical advancement in Cartesian Growth Corp III's de-SPAC merger with Factorial Inc. The SEC's declaration of effectiveness for the S-4 registration statement clears the final regulatory hurdle, allowing the company to proceed with the shareholder vote. The scheduled extraordinary general meeting on May 27, 2026, provides a definitive timeline for the merger's approval, with an anticipated closing in June. This progression is particularly significant given the "going concern" warning noted in the company's last 10-K, as the successful completion of this merger is crucial for Factorial's commercialization and manufacturing scale-up, supported by the $100 million PIPE and existing trust cash. The stock trading near its 52-week high and recent insider accumulation suggest positive market sentiment regarding the merger's prospects.
At the time of this filing, CGCT was trading at $10.40 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $358.8M. The 52-week trading range was $10.00 to $10.44. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.